Conavi Medical Statistics

Total Valuation

Conavi Medical has a market cap or net worth of CAD 44.50 million. The enterprise value is 63.10 million.

Market Cap	44.50M
Enterprise Value	63.10M

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Conavi Medical has 103.49 million shares outstanding. The number of shares has increased by 349.18% in one year.

Current Share Class	103.49M
Shares Outstanding	103.49M
Shares Change (YoY)	+349.18%
Shares Change (QoQ)	-12.39%
Owned by Insiders (%)	0.65%
Owned by Institutions (%)	0.00%
Float	68.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	63.03
PB Ratio	-2.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.90
EV / Sales	89.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.05

Financial Position

The company has a current ratio of 0.60

Current Ratio	0.60
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.95
Interest Coverage	-21.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-7,676.14%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.68%
50-Day Moving Average	0.43
200-Day Moving Average	0.48
Relative Strength Index (RSI)	59.31
Average Volume (20 Days)	48,812

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Conavi Medical had revenue of CAD 706,000 and -16.19 million in losses. Loss per share was -0.24.

Revenue	706,000
Gross Profit	759,000
Operating Income	-20.27M
Pretax Income	-16.19M
Net Income	-16.19M
EBITDA	-19.81M
EBIT	-20.27M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 971,000 in cash and 19.57 million in debt, giving a net cash position of -18.60 million or -0.18 per share.

Cash & Cash Equivalents	971,000
Total Debt	19.57M
Net Cash	-18.60M
Net Cash Per Share	-0.18
Equity (Book Value)	-20.75M
Book Value Per Share	-0.27
Working Capital	-3.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.62 million and capital expenditures -74,000, giving a free cash flow of -20.70 million.

Operating Cash Flow	-20.62M
Capital Expenditures	-74,000
Free Cash Flow	-20.70M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross Margin	107.51%
Operating Margin	-2,870.40%
Pretax Margin	-2,292.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Conavi Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-349.18%
Shareholder Yield	-349.18%
Earnings Yield	-36.37%
FCF Yield	-46.51%

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	0.04

Scores

Conavi Medical has an Altman Z-Score of -30.65 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-30.65
Piotroski F-Score	1